Iktos raises €15.5M to expand AI drug discovery technologies
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
Iktos, a company specializing in artificial intelligence (AI) for new drug discovery, has closed a…
Antimicrobial peptides (AMPs) are a promising new weapon for combating the growing antimicrobial resistance (AMR)…
Cytovation ASA, a Norwegian clinical stage immune-oncology company focused on the development of CyPep-1, its…
IMV Inc. has announced positive preliminary data from its VITALIZE phase 2B trial. The study…
Researchers at Hokkaido University in Japan have developed a novel method to design and develop…
Orbit Discovery Limited has entered into a multi target research agreement with Endevica Bio Inc. …
The World Health Organization (WHO) ranks antibiotic resistance as one of the top 10 threats…
Orbit Discovery Limited has entered into a master service agreement with SanegeneBio Inc., a start-up…
A project to develop a patch worn on the cheek that delivers peptide treatments for…
By bringing the efficiency and affordability of vaccines to chronic diseases such as migraines, U.S.…
Clinical stage biopharma company Enterome has presented new data from its two phase 1/2 clinical…
Alume Biosciences, Inc. says the first patient has been dosed in a phase 3 pivotal…